Total Payments
$3,343
2021 Payments
$46.13
Companies
27
Transactions
162
Medicare Patients
4,549
Medicare Billing
$289,201
Payment Breakdown by Category
Food & Beverage$3,213 (96.1%)
Education$130.49 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,213 | 158 | 96.1% |
| Education | $130.49 | 4 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $926.81 | 41 | $0 (2020) |
| Janssen Biotech, Inc. | $871.88 | 32 | $0 (2020) |
| Dendreon Pharmaceuticals LLC | $251.25 | 12 | $0 (2020) |
| Boston Scientific Corporation | $135.40 | 9 | $0 (2020) |
| Allergan Inc. | $127.83 | 8 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $119.68 | 8 | $0 (2019) |
| Amgen Inc. | $107.38 | 5 | $0 (2019) |
| AbbVie, Inc. | $100.42 | 6 | $0 (2019) |
| MEDIVATION INC. | $83.97 | 5 | $0 (2017) |
| TOLMAR Pharmaceuticals, Inc. | $78.31 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $46.13 | 3 | Myovant Sciences Inc. ($28.23) |
| 2020 | $255.95 | 14 | Astellas Pharma US Inc ($91.93) |
| 2019 | $928.73 | 45 | Astellas Pharma US Inc ($376.93) |
| 2018 | $1,300 | 58 | Astellas Pharma US Inc ($336.42) |
| 2017 | $813.01 | 42 | Janssen Biotech, Inc. ($274.97) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2021 | Catalyst OrthoScience | Archer CSR Total Shoulder System (Device), Archer R1 Reverse Shoulder System | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Orthopedics | ||||||
| 08/06/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: HORMONE THERAPY | ||||||
| 03/17/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 03/12/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ONCOLOGY | ||||||
| 03/11/2020 | Dornier MedTech America, Inc | Lithotripters & Accessories (Device) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Urology | ||||||
| 03/11/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Oncology | ||||||
| 03/10/2020 | Coloplast Corp | SPEEDICATH (Device) | Education | Cash or cash equivalent | $14.82 | General |
| Category: CONTINENCE | ||||||
| 03/03/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: UROLOGY | ||||||
| 02/26/2020 | Boston Scientific Corporation | SPACEOAR (Device) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: BPH | ||||||
| 02/25/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/18/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2020 | Coloplast Corp | SPEEDICATH (Device) | Education | Cash or cash equivalent | $23.85 | General |
| Category: CONTINENCE | ||||||
| 01/30/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2020 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Prostate Cancer | ||||||
| 01/14/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: UROLOGY | ||||||
| 01/07/2020 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: UROLOGY | ||||||
| 12/20/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Oncology | ||||||
| 12/10/2019 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Oncology | ||||||
| 12/03/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: UROLOGY | ||||||
| 11/26/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $75.55 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2019 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
| 10/09/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Oncology | ||||||
| 09/25/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 649 | 853 | $189,009 | $40,945 |
| 2022 | 16 | 646 | 888 | $255,330 | $49,656 |
| 2021 | 18 | 1,242 | 1,620 | $297,927 | $63,952 |
| 2020 | 22 | 2,012 | 3,287 | $463,086 | $134,649 |
Total Patients
4,549
Total Services
6,648
Medicare Billing
$289,201
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 76 | 99 | $67,419 | $17,441 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 210 | $62,370 | $12,886 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 44 | $19,272 | $3,734 | 19.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 66 | 73 | $13,062 | $2,694 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $12,060 | $1,664 | 13.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 22 | $5,808 | $952.40 | 16.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 248 | 375 | $3,750 | $823.30 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $5,268 | $749.55 | 14.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 66 | 82 | $55,842 | $14,484 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 184 | $54,648 | $11,559 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $24,790 | $4,394 | 17.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 13 | 14 | $19,988 | $4,314 | 21.6% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 12 | 12 | $12,336 | $2,068 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 24 | $10,384 | $2,006 | 19.3% |
| 51705 | Simple change of bladder tube | Office | 2022 | 11 | 24 | $9,048 | $1,683 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $10,975 | $1,658 | 15.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 15 | 36 | $9,504 | $1,549 | 16.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 40 | $7,160 | $1,546 | 21.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 15 | 18 | $28,866 | $1,521 | 5.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 16 | 16 | $4,648 | $1,250 | 26.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 200 | 335 | $3,350 | $732.76 | 21.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 12 | 12 | $1,584 | $544.44 | 34.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 14 | $1,232 | $249.72 | 20.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 13 | 15 | $975.00 | $96.48 | 9.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 274 | 329 | $78,513 | $17,847 | 22.7% |
About David Elkins, M.D., PH.D
David Elkins, M.D., PH.D is a Urology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821159187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Elkins, M.D., PH.D has received a total of $3,343 in payments from pharmaceutical and medical device companies, with $46.13 received in 2021. These payments were reported across 162 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,213).
As a Medicare-enrolled provider, Elkins has provided services to 4,549 Medicare beneficiaries, totaling 6,648 services with total Medicare billing of $289,201. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Salem, OR
- Active Since 12/12/2006
- Last Updated 07/07/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1821159187
Products in Payments
- XTANDI (Drug) $684.20
- Erleada (Drug) $527.23
- ZYTIGA (Drug) $357.41
- PROVENGE (Drug) $273.90
- MYRBETRIQ (Drug) $214.00
- XIAFLEX (Biological) $119.68
- Xtandi (Drug) $92.35
- Lupron (Drug) $83.07
- BOTOX THERAPEUTIC (Biological) $81.26
- ELIGARD (Drug) $78.31
- GREENLIGHT (Device) $71.58
- Prolia (Biological) $68.19
- Xofigo (Drug) $51.00
- BOTOX (Biological) $46.57
- VESICARE (Drug) $44.60
- XGEVA (Biological) $39.19
- SPEEDICATH (Device) $38.67
- REZUM (Device) $35.62
- FIRMAGON (Drug) $31.83
- Myrbetriq (Drug) $29.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Dr. Mark Laspina, D.o, D.O
Urology — Payments: $19,777
Urology $19,777
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Urology $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Urology $14,486
Bradley Warner, M.d, M.D
Urology — Payments: $10,038
Urology $10,038
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Urology $8,224
Dr. John Mhoon, M.d, M.D
Urology — Payments: $7,907
Urology $7,907